Nxera Pharma Co., Ltd.【JP:4565】Cash flow
Market cap
¥78.2B
P/E ratio
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | - | - | 879 | 1,489 | 1,350 | 1,278 | 1,345 | 2,478 | 3,984 |
| Cash from operations | 985 | 363 | 92 | 4,471 | 12,856 | -2,167 | -3,995 | 3,441 | 4,672 | 7,095 | 9,952 | -5,273 | -7,718 |
| Capital expenditures | - | - | - | - | - | - | -1,807 | -271 | -92 | -193 | -277 | -804 | -526 |
| Cash from investing | -185 | -315 | -22,018 | -337 | -2,327 | -6,148 | -2,808 | -246 | -150 | 278 | 1,043 | -63,791 | -4,763 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | - | - | - | 39,900 | - |
| Repayments of term debt | - | - | - | - | - | - | - | -7,000 | - | - | - | -1,450 | -5,800 |
| Cash from financing | 90 | 4,375 | 19,864 | 863 | -6,310 | 22,641 | -2,268 | -6,964 | 20,278 | 11,123 | -4,887 | 48,329 | -6,854 |